Cite
HARVARD Citation
Messori, A. et al. (2022). Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin's lymphoma: the survival gain improves as more mature follow-up data become available. European journal of hospital pharmacy. 29 (3), p. e1. [Online].